Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows
- PMID: 10490081
Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows
Abstract
Objective: To compare pharmacokinetic variables of enrofloxacin (ENR) after IV administration in mice, rats, rabbits, sheep, and cows and to perform allometric analysis of ENR.
Animals: 47 mice, 5 rats, 5 rabbits, 5 sheep, and 5 cows.
Procedure: Serially obtained plasma samples were assayed for ENR concentration, using high-performance liquid chromatography. In vitro plasma protein binding was determined by ultrafiltration. Plasma ENR concentration versus time curves were fitted by use of nonlinear least-squared regression analysis. Pharmacokinetic variables were correlated further with body weight.
Results: In all species studied, the best fit was obtained for a two-compartment open model; ENR half-life ranged from 89 minutes in mice to 169 minutes in cows. Volume of distribution was large in all species studied, with values ranging from 10.5 L/kg in mice to 1.5 L/kg in sheep. Body clearance ranged from 68.1 ml/min/kg for mice to 4.6 ml/min/kg for sheep. Unbound ENR was found to be (mean +/- SD) 58+/-2, 50+/-6, 50+/-2, 31+/-2, and 40+/-3% in plasma of mice, rats, rabbits, sheep, and cows, respectively. The only pharmacokinetic variables that could be correlated with body weight were elimination half-life, clearance, and volume of distribution. Allometric exponents denoting proportionality of half-life, body clearance, and volume of distribution with body weight were 0.06, 0.82, and 0.90, respectively.
Conclusions and clinical relevance: An allometric approach could provide a suitable method for determining a scale for ENR pharmacokinetics among various mammalian species. This would faciliatate the administration of appropriate doses of ENR to all animals.
Similar articles
-
Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring.Am J Vet Res. 1996 Apr;57(4):547-53. Am J Vet Res. 1996. PMID: 8712523
-
Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits.Am J Vet Res. 1992 Nov;53(11):2090-3. Am J Vet Res. 1992. PMID: 1334640
-
Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.Am J Vet Res. 1996 Jul;57(7):1040-3. Am J Vet Res. 1996. PMID: 8807018
-
[Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].Antibiot Khimioter. 1998;43(10):46-52. Antibiot Khimioter. 1998. PMID: 9825111 Review. Russian. No abstract available.
-
Pharmacokinetics and metabolism of Navelbine.Semin Oncol. 1989 Apr;16(2 Suppl 4):21-5. Semin Oncol. 1989. PMID: 2652317 Review. No abstract available.
Cited by
-
Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin following intravenous administration in buffalo calves (Bubalus bubalis).Vet Res Commun. 2009 Oct;33(7):659-67. doi: 10.1007/s11259-009-9215-6. Epub 2009 Mar 19. Vet Res Commun. 2009. PMID: 19296232
-
Allometric scaling of xenobiotic clearance: uncertainty versus universality.AAPS PharmSci. 2001;3(4):E29. doi: 10.1208/ps030429. AAPS PharmSci. 2001. PMID: 12049492 Free PMC article.
-
Preparation and evaluation of enrofloxacin microspheres and tissue distribution in rats.J Vet Sci. 2015;16(2):157-64. doi: 10.4142/jvs.2015.16.2.157. Epub 2015 Jan 30. J Vet Sci. 2015. PMID: 25643802 Free PMC article.
-
Altered pharmacokinetics of enrofloxacin in experimental models of hepatic and renal impairment.Vet Res Commun. 2009 Jun;33(5):481-7. doi: 10.1007/s11259-008-9195-y. Epub 2008 Dec 16. Vet Res Commun. 2009. PMID: 19085067
-
Systemic and mammary gland disposition of enrofloxacin in healthy sheep following intramammary administration.BMC Vet Res. 2015 Apr 9;11:88. doi: 10.1186/s12917-015-0406-9. BMC Vet Res. 2015. PMID: 25889369 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources